Czech biotech stands on stronger foundations than many still assume. Nearly 430 entities, CZK 97.5bn in annual revenue, and growing investor attention show real momentum. But further growth will depend on one thing: turning strong science into investable, scalable projects. #Biotech #Czechia

Boston is not just a location. It is a concentration of capital, experience, and decision-making. For Central European projects, that is not an abstract benchmark, but a different operating environment. Through IOCB Boston, we are already part of that ecosystem. #Biotech #TechTransfer #Boston

Join us at #BioEquity Europe 2026 for the Regional Host Panel: How to Bring Great Science to Market – The CEE Case. Julie Proft will join the discussion, moderated by Zuzana Válková, on what makes CEE science investable and how the region can build stronger biotech success. 📅 5 May 🕓 4:00 pm

Thank you very much to the @biovaria.bsky.social team for a great #BioVaria 2026. see you next year for #BioVaria2027 #innovation #BioTech

The afternoon session @biovaria.bsky.social 2026 is filled with 3 projects developed at @iocbprague.bsky.social - The SQM - Quantum Mechanical Scoring is starting off the trio. The team has already 3 Pharma partners & looking for more #BioVaria2026 #innovation #BioTech

Gasdermin inhibitors for the treatment of #stroke. A #smallmolecule program from #LDC & #KHANH presented @biovaria.bsky.social

@bihatcharite.bsky.social is opening the scientific part of #BioVaria2026 - Genome editing for the cure of #PR3-AAC patients. #techtransfer #innovation #biovaria

And so it starts @biovaria.bsky.social 2026. Looking forward to great technologies, interesting talks & networking. AND our yearly BlueSky battle #BioVaria2026 #techtransfer #innovation

Not every important step in life sciences starts with a new concept. Sometimes, it comes from making existing methods work better. Great to see LAM-X develop VerdiBlot and continue precise work on nanomaterials — thoughtful innovation in a part of science that often stays out of the spotlight.

Bio€quity Europe is almost here! From 4–6 May 2026, Prague will welcome investors, biotech companies, and tech transfer professionals for several days of partnering and discussion. For IOCB Tech, it is an important space where research, investment, and application meet. #BioEquity #Biotech

Some of the most important advances in life sciences are tools, not therapies. Great to see LAM-X introduce VerdiBlot, a new bioanalytical method building on Western blot with the aim of making protein analysis more reliable and easier to interpret. Congrats. #Bioanalysis #LifeSciences

Czechia is not lagging in research investment. Around 2% of GDP goes into R&D, and the scientific base is strong. The challenge is what comes next: turning research into companies, products, and market presence. That is where IOCB Tech works. #TechTransfer #Innovation

🇵🇹 We’re delighted to be at BIO-Europe Spring in beautiful Lisbon, Portugal, alongside our colleagues from Prague.bio Come and meet us at BOOTH 73. 🤝🧬 #BIOEuropeSpring #Lisbon #Biotech #LifeSciences #Networking #Innovation

🎧 Today’s podcast tip: Our colleague Martin Kovalčík from i&i Prague interviewed Jan Berka, who helps develop the portfolio of i&i Prague projects, in a new episode of #ChemagazinTalks. 👉 Link in comments 📷 Photo: i&i Prague #Biotech #Podcast #TechTransfer

“Who owns the work an AI produces — and how safe is our data, really?” 🤖 That’s why Matěj Malý and Kateřina Habelová joined a seminar at the Prague Innovation Institute on IP, AI & ethics in research (Feb 25), including what the European AI Act will mean in practice. 📷 Prague Innovation Institute

Today, we’re happy to spotlight Jana Kenney — Analyst & Project Manager at IOCB Tech. 👤🧬 Jana brings a sharp analytical mindset and a great feel for what it takes to move projects forward beyond the lab. #MeetTheTeam #IOCBTech #LifeSciences #TechnologyTransfer #TechTransfer #Biotech

🧬 Metabolism research is moving fast toward clinical impact — proud to support the Prague Metabolism & Signaling Symposium. More soon! #MetabolismSymposium (via @PragueMetabol on X)

Should biotech stay in the lab — or also help strengthen Europe’s security? 🛡️ 💬 “Given today’s geopolitics, we in biotech can’t ignore stability and safety,” says Matěj Malý (IOCB Tech). Feb 17: Czech Industry Day + EDF matchmaking. 🤝 🔗 lnkd.in/dzt93UFs #Biotech #Defence #EDF #Innovation

Throwback to our Czech delegation at BioVaria 2025 🇨🇿 Proud that IOCB Tech is a Power Partner of BioVaria 2026 — we’ll be back in Munich on 27–28 Apr.📍 A curated showcase of dozens of licensable life-science technologies + selected start-ups, with partnering that actually leads to follow-ups.🤝

📬 Worth a quick read: Press 13 (January 2026) from the Harvard Innovation Labs. And it’s also a good reminder why it matters that Ústav organické chemie a biochemie AV ČR has a presence in Boston through IOCB Boston 🇺🇸🔬 👉 Read the newsletter: lnkd.in/dkWJ9KJp #Boston #Cambridge #Innovation

📅 For anyone keeping an eye on what’s next in biotech, these dates are worth marking in your calendar in 2026 — they’re already in ours, and we look forward to engaging with many of you along the way. 🔗 Links in the comments ⬇️ #TechTransfer #LifeSciences #Biotech #Events2026

🇱🇺 In Luxembourg, Petr Zelenka’s Elegance of the Molecule opened a window into the moment when a scientific idea first takes shape — inspired by discoveries of Czech chemist Antonín Holý. It’s a reminder for Europe’s innovators to keep an eye on the new stories emerging in Czechia. #TechTransfer

Science met theatre last night in Luxembourg — and the result was a powerful reminder of how stories shape discovery. The Elegance of the Molecule by Dejvické divadlo brought researchers, actors, founders and diplomats onto one stage — and into one storyworld. #LifeSciences #TechTransfer #Luxembourg

✨It’s official: Julie Proft is stepping into the role of Deputy Director of IOCB Tech. Julie has been part of IOCB Tech since 2016 and brings a rare combination of scientific insight, international experience, and a keen sense for how technology transfer works in practice. #MeetTheTeam #TechTransfer

What does leadership built on experience and driven by a commitment to excellence look like? Meet Milan Prášil, CEO of IOCB Tech — the first profile in our new #MeetTheTeam series. #TechTransfer #LifeSciences #Innovation

We will be there, will you? #boston Join us for an evening of introductions, excitement, and chemistry that makes a difference — bridging discovery and medicine, Prague and Boston, ideas and action. Read the full post by #IOCBBoston on LinkedIn⤵️: www.linkedin.com/company/5093...

“My dream is to capture air and separate air to - for instance, in CO₂ or oxygen or water or something - and convert this to useful materials using renewable energy.” 🧬Susumu Kitagawa, Nobel Prize 2025 At IOCB Tech we believe that science finds its true voice when it speaks beyond the lab.

The 2025 Nobel Prize in Chemistry goes to Makoto Fujita, Omar Yaghi & Susumu Kitagawa for creating MOFs — molecular frameworks that harvest water from desert air, capture CO₂, or store toxic gases. That’s what #TechTransfer is about — turning science into impact. 📸 Royal Swedish Academy of Sciences

🍸The formula proved simple: collaborate, stir, repeat.
One more toast to the IOCB Tech crew — the shared effort made the last IOCB Happy Hours click — and a quiet cheer for Ladislava, our patent attorney, for her steady behind-the-scenes support.✨ #TechTransfer #LifeSciences #Innovation #networking

🍸 Had it not been for our innate modesty, we’d call last night’s Happy Hours a roaring success. Thank you for bringing the spark — and to the IOCB Tech team for dedication.✨ #TechTransfer #LifeSciences #Innovation #Networking

Great news come in pairs! ✨ Thrilled to welcome Vijay Miriyala to IOCB Tech. His resolve, experience, and energy will help us keep building momentum for impact. 🍀 #TechTransfer #LifeSciences #Innovation

Thrilled to welcome Matěj Malý to IOCB Tech! Science becomes innovation through people who connect the dots – and his expertise will help us do just that. #TechTransfer #LifeSciences #Innovation

We are happy we were able to support the #CECAM Flagship Workshop at @iocbprague.bsky.social last week. #compchem #SQM #TransferingKnowledge #techtransfer

Opening panel at #Bio€quity 2025 „Biotech‘s complex moment - what’s next for Europe?“ #investments #Biotech

Such an interesting presentation by @dieWissenschaftlerin yesterday at #BioVaria2025

We r happy Martin will still be around, sharing his knowledge and wisdom with us. And we r looking forward to our new chapter with Milan Prasil as CEO. He had a great start by handing over the price for the best arising #startup at #BioVaria2025 #BioVaria #TechTransfer

Thank you for a great even @biovaria.bsky.social It’s always great to connect with #TTOs from all over Europe. See you & @asceniongmbh.bsky.social 2026 for #BioVaria2026 or before for our #PragueBio conference September 25, 2025 in Prague Via www.Prague.bio

Prof. Dr. med. Thomas Rauen @rwth.bsky.social discovered & established novel #Biomarkers for non-invasive diagnostic of #LupusNephritis #BioVaria2025 #BioVaria #autoimmune #diagnostic

Gabo Birkus from @iocbprague.bsky.social is opening the last presentation stream at #BioVaria2025 #cGAS #CD3 #BioVaria #autoimmune

At @iocbprague.bsky.social we r developing cGAS inhibitors together with #CD3 Leuven. Gabo Birkus is presenting @biovaria.bsky.social about our peripheral and CNS #cGasInhibitors right now. #BioVaria #BioVaria2025 #LifeScience

This session will have a presentation from @charlesuni.cuni.cz together with @iocbprague.bsky.social and a project from @vschtpraha.bsky.social #czechScience #BioVaria2025 #BioVaria

Neuroscience and Pharmaceutical Innovations take the stage at the third presentation stream - Learn more about these technologies and their vision, and connect with the innovators at #Biovaria 2025! #biotech #technologies #networking #Innovation #Neuroscience #pharmaceuticals

Klara Saskova is currently presenting @biovaria.bsky.social 2025. The team from @charlesuni.cuni.cz & @iocbprague.bsky.social developed small molecules to activate the proteasome to treat #neurodegeneration #BioVaria #Huntington #BioVaria2025

Our 1st talk out of 6 at #BioVaria2025 by Prof Hana Lisalova from @fzuavcr.bsky.social. Introducing “FunBrush” #BioVaria #TechnologyTransfer

At @maxplanck.de scientist want to make diagnostic as easy as using a tricorder. #StarTrek meets #LifeScience at @biovaria.bsky.social 2025. #BioVaria2025 #BioVaria

Unfortunately, Corona viruses r still around. To be better prepared for future outbreaks, scientists @uniheidelberg.bsky.social developing novel inhibitors against a brought spectrum of corona viruses. #BioVaria #BioVaria2025 #TechnologyTransfer #LifeScience

We r happy to be part of #BioVaria2025 and looking forward to 2 days full of great #technologies and #Networking

In a collaborative approach @helmholtzhzi.bsky.social, #HannoverMedicalSchool, @volkswagenstiftung.de & @dzif.bsky.social r developing novel inhibitor against #RSV infections, a huge problem in young children and older people. Presenting now at #BioVaria2025 #TechTransfer #BioVaria

[email protected] is presenting at #BioVaria2025 the future of #vaccines. A 1 shot solution for long lasting #immunity, lowering cost & higher compliance. #TechTransfer #startups #BioVaria

1st session @Biovaria is chaired by Jűrgen Walkenhorst from @Provendis “infectious disease control” #BioVaria #BioVaria2025 #techtransfer